Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

No established second-line chemotherapy is available for patients with advanced gastric cancer failing to respond or progressing to first-line chemotherapy. However, 20–40% of these patients commonly receive second-line chemotherapy. We evaluated the influence of clinico-pathologic factors on the su...

Descripción completa

Detalles Bibliográficos
Autores principales: Catalano, V, Graziano, F, Santini, D, D'Emidio, S, Baldelli, A M, Rossi, D, Vincenzi, B, Giordani, P, Alessandroni, P, Testa, E, Tonini, G, Catalano, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579675/
https://www.ncbi.nlm.nih.gov/pubmed/18971936
http://dx.doi.org/10.1038/sj.bjc.6604732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579675/
https://www.ncbi.nlm.nih.gov/pubmed/18971936
http://dx.doi.org/10.1038/sj.bjc.6604732

Ejemplares similares